SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells
2020 · Cancer Cell International · 51 citations
https://doi.org/10.1186/s12935-020-01291-y
Luoyang Central Hospital Affiliated to Zhengzhou University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
116
Citations
3
h-index
3
i10-index
Zhaoying Xu is an academic researcher from Luoyang Central Hospital Affiliated to Zhengzhou University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Retinal Diseases and Treatments & Mitochondrial Function and Pathology. The author has an h-index of 3, co-authored 4 publications.
Click to start Chat